Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 5, 1996, Pages 511-516

  Powers, Douglas C ^a,b   Kilbourne, Edwin D ^c   Johansson, Bert E ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; VIRUS ANTIBODY; VIRUS SIALIDASE;

AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLUENZA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0029793358     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.5.511-516.1996     Document Type: Article

References (20)

1. Clements, M. L., and B. R. Murphy. 1986. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J. Clin. Microbiol. 23:66-72.
2. Coles, F. B., G. J. Balzano, and D. L. Morse. 1992. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J. Am. Geriatr. Soc. 40:589-592.
3. Couch, R. B., J. A. Kasel, J. L. Gerin, J. L. Schulman, and E. D. Kilbourne. 1974. Induction of partial immunity to influenza by a neuraminidase-spccific vaccine. J. Infect. Dis. 129:411-420.
4. Fedson, D. S., R. V. Fulk, M. A. Huber, M. A. Reisberg, and J. A. Kasel. 1971. Antineuraminidase antibody response in scrum and nasal secretions following intranasal or subcutaneous inactivated A2/Hong Kong/68 influenza virus vaccine. J. Immunol. 107:730-737.
5. Feery, B. J., M. G. Evered, and E. Morrison. 1979. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J. Infect. Dis. 139:237-241.
6. Gross, P. A., F. A. Ennis, P. F. Gaerlan, L. J. Denson, C. R. Denning, and D. Schiffman. 1977. A controlled double-blind comparison of the reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J. Infect. Dis. 136:623-632.
7. Hammarström, L., and C. I. Edvard Smith. 1986. IgG subclass changes in response to vaccination. Monogr. Allergy 19:241-252.
8. Hobson, D., R. C. Curry, A. S. Beare, and A. Ward-Gardner. 1973. Hemagglutination inhibition antibody liters as a measure of protection against influenza in man. Dev. Biol. Stand. 20:164-168.
9. Hocart, M. J., J. S. Mackenzie, and G. A. Stewart. 1990. Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A. J. Med. Virol. 30:92-96.
10. Immunization Practices Advisory Committee. 1994. Prevention and control of influenza, part I. Vaccines. Morbid. Mortal. Weekly Rep. 43:1-13.
11. Jahiel, R. I., and E. D. Kilbourne. 1966. Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions. J. Bacteriol. 92:1521-1534.
12. Johansson, B. E., D. J. Bucher, and E. D. Kilbourne. 1989. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 63:1239-1246.
13. Johansson, B. E., and E. D. Kilbourne. 1993. Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. J. Virol. 67:5721-5723.
14. H cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proe. Nail. Acad. Sci. USA 84:6869-6873.
15. Kasel, J. A., R. B. Couch, H. R. Six, and V. Knight. 1976. Antigenicity of licensed whole virion and subvirion influenza vaccines in "high risk" persons. Proc. Soc. Exp. Biol. Med. 151:742-747.
16. Kendal, A. P., F. M. Bozeman, and F. A. Ennis. 1980. Further studies of the neuraminidase content of inactivated influenza vaccines and the neuramin-idase antibody responses after vaccination of immunologically primed and unprimed populations. Infect. Immun. 29:966-971.
17. Kendal, A. P., and W. R. Dowdle. 1986. Influenza virus, p. 515-520. In N. R. Rose, H. Friedman, and J. L. Fahey (ed.), Manual of clinical laboratory immunology, 3rd ed. American Society for Microbiology, Washington, D.C.
18. Kendal, A. P., E. Minuse, H. F. Maassab, A. V. Hennessy, and F. M. Davenport. 1973. Influenza neuraminidase antibody patterns of man. Am. J. Epidemiol. 98:96-103.
19. Kendal, A. P., G. R. Noble, and W. R. Dondle. 1977. Neuraminidase content of influenza vaccines and ncuraminidase antibody responses after vaccination of immunologieally primed and unprimed populations. J. Infect. Dis. 136:5415-5424.
20. Kida, H., R. G. Webster, and R. Yanagawa. 1983. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/Seal/Massachusctts/1/80 (H7N7) influenza virus. Arch. Virol. 76:91-99.